Stephen Villano

4.7k total citations
52 papers, 3.5k citations indexed

About

Stephen Villano is a scholar working on Epidemiology, Oncology and Pharmacology. According to data from OpenAlex, Stephen Villano has authored 52 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 12 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Stephen Villano's work include Cytomegalovirus and herpesvirus research (17 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Polyomavirus and related diseases (10 papers). Stephen Villano is often cited by papers focused on Cytomegalovirus and herpesvirus research (17 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Polyomavirus and related diseases (10 papers). Stephen Villano collaborates with scholars based in United States, Germany and Canada. Stephen Villano's co-authors include Kenrad E. Nelson, David Vlahov, David L. Thomas, Sylvia Cohn, Judith N. Steenbergen, Sébastien Tanaka, Evan Loh, David L. Thomas, Michael Boeckh and Genovefa A. Papanicolaou and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

Stephen Villano

48 papers receiving 3.4k citations

Peers

Stephen Villano

EPIDE

HEPAT

ONCOL

Pierre–Yves Bochud Switzerland

Elisa Cordero Spain

Fehmı Tabak Türkiye

Frederick S. Nolte United States

Carlos Cervera Spain

P. Chavanet France

Antonio Rivero Spain

María Ángeles Marcos Spain

Esteban Ribera Spain

Jesús Fortün Spain

Pierre–Yves Bochud Switzerland

Stephen Villano

2.9k ×1.1

EPIDE

1.2k ×1.0

1.5k ×1.4

HEPAT

506 ×1.2

ONCOL

118 ×0.3

Citations per year, relative to Stephen Villano Stephen Villano (= 1×) peers Pierre–Yves Bochud

Countries citing papers authored by Stephen Villano

Since Specialization

Citations

This map shows the geographic impact of Stephen Villano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Villano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Villano more than expected).

Fields of papers citing papers by Stephen Villano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Villano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Villano. The network helps show where Stephen Villano may publish in the future.

Co-authorship network of co-authors of Stephen Villano

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Villano. A scholar is included among the top collaborators of Stephen Villano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Villano. Stephen Villano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winthrop, Kevin, et al.. (2025). A Phase 2, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Omadacycline in Adults With Nontuberculous Mycobacterial Pulmonary Disease (NTM PD) Caused by Mycobacterium Abscessus Complex (MABc). American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3168–A3168.

File, Thomas M., Keith S. Kaye, Kushagra Gupta, et al.. (2025). Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial. EClinicalMedicine. 90. 103656–103656.

Ansell, Jack, Bryan Laulicht, Sasha Bakhru, et al.. (2020). Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants. Blood. 137(1). 115–125. 42 indexed citations

Popescu, Monica, Ismail Mitha, Andrzej Madej, et al.. (2017). A Phase 3 Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of IV to Oral Omadacycline to Moxifloxacin for the Treatment of Adult Subjects with CABP (The OPTIC Study). Open Forum Infectious Diseases. 4(suppl_1). S543–S544. 11 indexed citations

Tanaka, Sébastien, Judith N. Steenbergen, & Stephen Villano. (2016). Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic. Bioorganic & Medicinal Chemistry. 24(24). 6409–6419. 83 indexed citations

Tzanis, Evan, Amy Manley, Stephen Villano, et al.. (2016). Effect of Food on the Bioavailability of Omadacycline in Healthy Participants. The Journal of Clinical Pharmacology. 57(3). 321–327. 37 indexed citations

Chou, Sunwen, Morgan Hakki, & Stephen Villano. (2012). Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo. Antiviral Research. 95(2). 88–92. 22 indexed citations

Marty, Francisco M., Per Ljungman, Genovefa A. Papanicolaou, et al.. (2011). Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. The Lancet Infectious Diseases. 11(4). 284–292. 252 indexed citations

Avery, Robin K., Francisco M. Marty, Lynne Strasfeld, et al.. (2010). Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients. Transplant Infectious Disease. 12(6). 489–496. 93 indexed citations

10.

Strasfeld, Lynne, Ingi Lee, Walter A. Tatarowicz, Stephen Villano, & Sunwen Chou. (2010). Virologic Characterization of Multidrug‐Resistant Cytomegalovirus Infection in 2 Transplant Recipients Treated with Maribavir. The Journal of Infectious Diseases. 202(1). 104–108. 46 indexed citations

11.

Pescovitz, Mark D., et al.. (2009). A Randomized, Double-Blind, Pharmacokinetic Study of Oral Maribavir with Tacrolimus in Stable Renal Transplant Recipients. American Journal of Transplantation. 9(10). 2324–2330. 35 indexed citations

12.

Winston, Drew J., Jo‐Anne H. Young, Vinod Pullarkat, et al.. (2008). Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood. 111(11). 5403–5410. 177 indexed citations

13.

Kneteman, Norman M., Anita Y. M. Howe, Tiejun Gao, et al.. (2008). HCV796. Hepatology. 49(3). 745–752. 98 indexed citations

14.

Swan, Suzanne K., William Smith, Thomas Marbury, et al.. (2007). Pharmacokinetics of Maribavir, a Novel Oral Anticytomegalovirus Agent, in Subjects With Varying Degrees of Renal Impairment. The Journal of Clinical Pharmacology. 47(2). 209–217. 27 indexed citations

15.

Ma, Jian‐Gong, A NAFZIGER, Stephen Villano, Jennifer Victory, & Joseph Bertino. (2005). Single and multiple dose pharmacokinetics (PK) of maribavir (MB) in healthy adults. Clinical Pharmacology & Therapeutics. 77(2). P19–P19. 1 indexed citations

16.

Gibson, Michael K., Stephen Villano, Carol Ann Huff, & Joseph Cofrancesco. (1999). Recrudescence of CutaneousMycobacterium haemophilumLesions Following Tetanus Immunization. Clinical Infectious Diseases. 28(4). 919–912. 4 indexed citations

17.

Villano, Stephen, David Vlahov, Kenrad E. Nelson, Sylvia Cohn, & David L. Thomas. (1999). Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection. Hepatology. 29(3). 908–914. 359 indexed citations

18.

Thomas, David L., Stephen Villano, Katherine Riester, et al.. (1998). Perinatal Transmission of Hepatitis C Virus from Human Immunodeficiency Virus Type 1‐Infected Mothers. The Journal of Infectious Diseases. 177(6). 1480–1488. 174 indexed citations

19.

Villano, Stephen, Kenrad E. Nelson, David Vlahov, et al.. (1997). Hepatitis A Among Homosexual Men and Injection Drug Users: More Evidence for Vaccination. Clinical Infectious Diseases. 25(3). 726–728. 83 indexed citations

20.

Villano, Stephen, David Vlahov, Kenrad E. Nelson, et al.. (1997). Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology. 35(12). 3274–3277. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact